Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 USD | -4.25% | +4.48% | -1.06% |
09/05 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/03 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NKARTA, INC. | Bio Therapeutic Drugs | -4.25% | +4.48% | -1.06% | +45.76% | - | 460M |
- Stock Market
- Equities
- NKTX Stock
- Charts Nkarta, Inc.
- Relative Strength Chart